Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1966 Mar;19(2):154–158. doi: 10.1136/jcp.19.2.154

Effects on blood coagulation, fibrinolysis, and platelet aggregation of normal and atheromatous aortic tissue

C R M Prentice 1, G P McNicol 1, A S Douglas 1
PMCID: PMC473217  PMID: 5909696

Abstract

A comparison was made between the effects of atheromatous and normal areas of the same aorta on coagulation, fibrinolytic, and platelet aggregating systems.

In the thromboplastin generation test it was found that atheromatous aorta possessed significantly greater ability to generate intrinsic prothrombin activator than did normal aortic tissue. But, by the one-stage prothrombin time technique, the content of extrinsic thromboplastin in both types of aorta was similar.

Aortic preparations, consisting of intimal and medial layers only, were not found to possess fibrinolytic ability and did not contain inhibitors of the fibrinolytic system.

The adhesion of platelets to ulcerated atheromatous areas of aorta was significantly greater than to normal or non-ulcerated atheromatous areas. However, homogenates of atheromatous and normal aorta did not differ in their ability to accelerate platelet aggregation and fibrin clot formation when tested by a modified Chandler's tube technique.

The significance of the findings is discussed and the suggestion made that the mechanisms by which atheromatous aortic tissue might predispose towards intravascular thrombosis in vivo are the ability of such tissue to enhance intrinsic prothrombin activator formation and platelet aggregation.

Full text

PDF
155

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., ABE T., SEEGERS W. H. Purification and quantitative determination of platelet factor 3. Am J Physiol. 1955 May;181(2):304–308. doi: 10.1152/ajplegacy.1955.181.2.304. [DOI] [PubMed] [Google Scholar]
  2. ALKJAERSIG N., FLETCHER A. P., SHERRY S. The mechanism of clot dissolution by plasmin. J Clin Invest. 1959 Jul;38(7):1086–1095. doi: 10.1172/JCI103885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. ASTRUP T., ALBRECHTSEN O. K., CLAASSEN M., RASMUSSEN J. Thromboplastic and fibrinolytic activity of the human aorta. Circ Res. 1959 Nov;7:969–976. doi: 10.1161/01.res.7.6.969. [DOI] [PubMed] [Google Scholar]
  4. BIGGS R., DOUGLAS A. S. The thromboplastin generation test. J Clin Pathol. 1953 Feb;6(1):23–29. doi: 10.1136/jcp.6.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CHANDLER A. B. In vitro thrombotic coagulation of the blood; a method for producing a thrombus. Lab Invest. 1958 Mar-Apr;7(2):110–114. [PubMed] [Google Scholar]
  6. COTTON R. E., HARWOOD T. R., WARTMAN W. B. Regeneration of aortic endothelium. J Pathol Bacteriol. 1961 Jan;81:175–180. doi: 10.1002/path.1700810121. [DOI] [PubMed] [Google Scholar]
  7. CRAWFORD T., DEXTER D., TEARE R. D. Coronary-artery pathology in sudden death from myocardial ischaemia. A comparison by age-groups. Lancet. 1961 Jan 28;1(7170):181–185. doi: 10.1016/s0140-6736(61)91363-0. [DOI] [PubMed] [Google Scholar]
  8. CUNNINGHAM G. M., MCNICOL G. P., DOUGLAS A. S. EFFECT OF ANTICOAGULANT DRUGS ON PLATELET AGGREGATION IN THE CHANDLER'S TUBE. Lancet. 1965 Apr 3;1(7388):729–730. doi: 10.1016/s0140-6736(65)92089-1. [DOI] [PubMed] [Google Scholar]
  9. DAEMEN F. J., VAN ARKEL, HART H. C., VAN DER DRIFT C., VAN DEENEN L. ACTIVITY OF SYNTHETIC PHOSPHOLIPIDS IN BLOOD COAGULATION. Thromb Diath Haemorrh. 1965 Mar 15;13:194–217. [PubMed] [Google Scholar]
  10. DONNER L. Some coagulant properties of the arterial wall in atherosclerosis. J Atheroscler Res. 1962 Jan-Apr;2:88–95. doi: 10.1016/s0368-1319(62)80056-8. [DOI] [PubMed] [Google Scholar]
  11. HUGUES J. [Binding of platelets to collagen]. C R Seances Soc Biol Fil. 1960;154:866–868. [PubMed] [Google Scholar]
  12. JOHNSON S. A., SCHNEIDER C. L. The existence of antifibrinolysin activity in platelets. Science. 1953 Feb 27;117(3035):229–230. [PubMed] [Google Scholar]
  13. KOWALSKI E., KOPEC M., LATALLO Z., ROSZKOWSKI S., SENDYS N. On the occurrence of a plasminogen-like substance in human tissues. Blood. 1958 May;13(5):436–446. [PubMed] [Google Scholar]
  14. KWAAN H. C., MCFADZEAN A. J. On plasma fibrinolytic activity induced by ischaemia. Clin Sci. 1956 May;15(2):245–257. [PubMed] [Google Scholar]
  15. MCNICOL G. P., BAIN W. H., WALKER F., RIFKIND B. M., DOUGLAS A. S. THROMBOLYSIS STUDIED IN AN ARTIFICIAL CIRCULATION: THROMBI PREPARED IN VITRO IN A CHANDLER'S TUBE. Lancet. 1965 Apr 17;1(7390):838–842. doi: 10.1016/s0140-6736(65)91375-9. [DOI] [PubMed] [Google Scholar]
  16. MITCHELL J. R., SHARP A. A. PLATELET CLUMPING IN VITRO. Br J Haematol. 1964 Jan;10:78–93. doi: 10.1111/j.1365-2141.1964.tb00681.x. [DOI] [PubMed] [Google Scholar]
  17. MUSTARD J. F., ROWSELL H. C., MURPHY E. A. THROMBOSIS. Am J Med Sci. 1964 Oct;248:469–496. [PubMed] [Google Scholar]
  18. PICKERING G. PATHOGENESIS OF MYOCARDIAL AND CEREBRAL INFARCTION: NODULAR ARTERIOSCLEROSIS. Br Med J. 1964 Feb 29;1(5382):517–529. doi: 10.1136/bmj.1.5382.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. POOLE J. C., FRENCH J. E. Thrombosis. J Atheroscler Res. 1961 Jul-Aug;1:251–282. doi: 10.1016/s0368-1319(61)80001-x. [DOI] [PubMed] [Google Scholar]
  20. REMMERT L. F., COHEN P. P. Partial purification and properties of a proteolytic enzyme of human serum. J Biol Chem. 1949 Nov;181(1):431–448. [PubMed] [Google Scholar]
  21. RUSSELL R. W. Observations on the retinal blood-vessels in monocular blindness. Lancet. 1961 Dec 30;2(7218):1422–1428. doi: 10.1016/s0140-6736(61)91247-8. [DOI] [PubMed] [Google Scholar]
  22. SAWYER P. N., PATE J. W. Electrical potential differences across the normal aorta and aortic grafts of dogs. Am J Physiol. 1953 Oct;175(1):113–117. doi: 10.1152/ajplegacy.1953.175.1.113. [DOI] [PubMed] [Google Scholar]
  23. SHERRY S., LINDEMEYER R. I., FLETCHER A. P., ALKJAERSIG N. Studies on enhanced fibrinolytic activity in man. J Clin Invest. 1959 May;38(5):810–822. doi: 10.1172/JCI103863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. TODD A. S. LOCALIZATION OF FIBRINOLYTIC ACTIVITY IN TISSUES. Br Med Bull. 1964 Sep;20:210–212. doi: 10.1093/oxfordjournals.bmb.a070333. [DOI] [PubMed] [Google Scholar]
  25. TROUP S. B., REED C. F., MARINETTI G. V., SWISHER S. N. Thromboplastic factors in platelets and red blood cells: observations on their chemical nature and function in vitro coagulation. J Clin Invest. 1960 Feb;39:342–351. doi: 10.1172/JCI104045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. WARREN B. A. FIBRIONLYTIC ACTIVITY OF VASCULAR ENDOTHELIUM. Br Med Bull. 1964 Sep;20:213–214. doi: 10.1093/oxfordjournals.bmb.a070334. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES